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Summary
as a hydrogen carrier between cytoplasmic-reduced glutathione (which appears to penetrate membranes poorly) and &tralysoso-Cysteamine is the most effective agent known for the reduction mal cystine. A genetic deficiency in endogenous cystearnine genof the elevated cystine content of cells from patients with cysti-eration might therefore lead to diminished capacity for intralysonosis. A defect in endogenous cysteamine generation could ac-somal reduction of cysthe to cysteke, a molecule to which the count for many of the metabolic features of this disorder. To test lysosomal membrane should be permeable (33) and hence could this we have for measur-be the fundamental etiology of abnormal cysthe accumulation in ing pantetheinase (cysteamine-generating) activity and intracellu-cystinosis. lar cysteamine levels and used these methods to measure such Cystearnine (Fig. is generated in animals by only one known parameters in cystinotic and normal leukocytes and cultured skin mechanism: the irreversible enzymatic cleavage of pantetheine fibroblasts. Pantetheinase activity as defined in the text was tPTSH 14-17). 9.4 f 1.5; cystinotic, 7.7 2 1.71. Cysteamine levels were normal in There is some evidence that pantetheinase is present in both leukocytes from c~stinotics receiving no 'ysteamine Or doses of soluble and lysosomal-microsomal cell fractions. This enzyme has oral cysteamine too low to reduce leukocyte cystine content. The not previously been described in human cells or tissues. results indicate that the cause of cystinosis is unlikely to be related Pantetheinase activity has been determined by several methods. to a failure to generate or sustain normal intracellular cysteamine levels.
One involves quantitation of pantothenic acid (PoA), an end product of PTSH cleavage, using a microbiological assay in which PoA is a necessary growth factor (e.g., using Lactobacillus arabiSpeculation nosus) (2, 5, 9, 10, 39) . The radiochemical assay of Dupre et al. (6, cystearnine is an extremely effective cystine depleting agent for 14-17) utilizes labeled PTSH as substrate and measures radioaccystinotic fibroblasts in vitro and can greatly reduce cystinotic tive product after PTSH. A pHleukocyte cystine content in vivo. Its pharmacologic properties Stat has been proposed (l l). The first is time suggest that it might prove to be of value in the therapy of consuming and proved erratic in our hands, whereas the radicystinosis. However, we do not believe that a defect in endogenous Ochemical assay requires an radiolabeled substrate cysteamine generation is a characteristic of cystinotic cells. The which must be We therefore a eventual elucidation of the cystinotic defect may require analysis system for low levels pantetheinase of the permeability characteristics of cystinotic ~ysosomes or the activity in small cell samples; our assay involves rapid quantitation discovery of presently unidentified pathways for lysosomal metab-MEA On an acid after generation PTSH olism of cystine.
and reaction with N-ethylmaleimide (NEM). The present report describes our use of this new method to determine panthetheinase activity and define certain properties of Cystinosis, a metabolic disease inherited as an autosomal Feces-this enzyme in extracts of cultured skin fibroblasts and freshly sive trait, is characterized by abnormal intralysosomal accumula-harvested leukocytes from normal and cystinotic subjects. We also tion of L-cystine in most cells of the body (32, 36) . The progressive attempted to directly measure cystearnine levels in these cells. accumulation of cystine leads to eventual destruction of cells, most notably in the kidney, and terminal renal failure by the second MATERIALS AND METHODS decade of life is characteristic of the most Severe and common nephropathic variant. The fundamental biochemical defect un-TISSUE CULTURE derlying this disorder has yet to be elucidated.
The apparently major mechanism for reduction of cystine in Skin fibroblasts matched for passage number from normal, normal cells involves enzymatically catalyzed glutathione-cystine cystinotic, and heterozygous (for cystinosis) subjects were grown transhydrogenation. Studies of this and other disulfide reducing to confluency at 37OC in a 5% C02/95% air atmosphere in roller systems have failed to define the abnormality causing cystinosis bottles or 75 cm2 plastic Falcon tissue culture flasks. They were (28, 29, (44) (45) (46) (47) . cultured in Eagle's minimal essential medium with added nonesCysteamine [mercaptoethylamine (MEA)] is a naturally occur-sential amino acids, 2 mM glutamine, 10% fetal calf serum, and ring, freely soluble sullydryl compound which readily penetrates 100 pg/ml neomycin, penicillin, and streptomycin. At harvesting, many biologic membranes. When supplied exogenously, it is the medium was decanted, the monolayer was washed three times highly effective in reducing the elevated cystine content of cystin-with isotonic phosphate-buffered saline, and the cells were deotic cells in vitro, presumably by entering the cystinotic lysosomes tached with brief exposure to 0.25% trypsin in PBS at 37°C. A and reducing cystine to the smaller and more soluble cysteine. A small amount of fresh medium was added to stop the reaction, suggested mechanism for cysteamine-mediated cystine depletion and the detached cells were collected and washed three times with has been discussed previously (42) . In this model, cysteamine acts cold phosphate-buffered saline using repetitive low-speed centrif- 
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ugation and gentle resuspension. The pellet was then sonicated in assay buffer at 4OC in 10-sec bursts for a total of 60 sec. The sonicate was kept at 4°C and used within several hours for enzyme assay. Total protein was determined by the method of Lowry et al. (23) .
LEUKOCYTE [WHITE BLOOD CELL (WBC)] PREPARATION
O lo p
Five to 10 ml of freshly drawn heparinized blood was obtained from normal volunteers, cystinotic patients, and their parents (obligate heterozygotes). Blood was mixed with an equal volume of 4% dextran or Plasmagel. After sedimentation at 25OC for approximately 30 min, the supernatant was collected, the WBC concentrated by centrifugation, and the residual erythrocytes removed using three hypotonic lyses (30, 37). The WBC pellet was then resuspended in cold buffer and sonicated and used like the fibroblasts.
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ASSAY TECHNIQUES
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All reagents were highest purity or Analar grades. Commercially obtained pantethine (PTSS) was checked for purity using a Beckman 121M amino acid analyzer and high-voltage electrophoresis and found to have a variety of contaminants. Repurification was achieved using Dowex 50W, 8X 200 to 400 mesh, H+ resin (Biorad) in a 0.6 x 4 cm column. One ml of a 50 mg/5 ml H20 stock solution of PTSS (kept frozen) was applied to the column and eluted with 1 ml of 0.1 N HCl and 2.5 ml of H20. Buffer was added to give a final PTSS concentration of 4 mM, and pH was adjusted to 7.6 for use in the assay. [Except where noted, buffer was 0.05 M potassium phosphate (pH 7.6)].
To reduce PTSS to PTSH, dithiothreitol (DTT) was used. Like PTSS, the DTT was passed over a Dowex 50 column and eluted with water. It was then diluted in buffer to give an 8 mM solution and was used immediately in the assay. Reducing power is lowered approximately 10% (as checked by DTNB) by this purification.
In the pantetheinase assay, all solutions were equilibrated with nitrogen, and the reaction was carried out under nitrogen in a 1.5 ml capped Beckman conical Microfuge tube. PTSS (0.2 pmoles) and 0.4 pmoles DTT in buffer were combined and vortexed, and after 5 rnin EDTA was added to a final concentration of lop3 M. EDTA was used to inhibit possible subsequent oxidation of generated cysteamine to hypotaurine (7, 12, 13-20, 22, 48, 50). After 10 min of preincubation at 37OC, cell extract in buffer preequalibrated with nitrogen was added, the tube was gassed with nitrogen, and the cap was tightened. Final rection volume was 0.5 ml. The mixture was generally incubated for 90 rnin (WBC) or 240 min (fibroblasts) with oscillation in a water bath at 37OC; inversion of the tube was carried out every 30 min. At the conclusion of incubation, the reaction mixture was placed on ice and an additional 0.2 pmole of buffered DTT (8 mM) was added. After 10 min, 2 pmoles NEM (20 mM in buffer) were added with mixing. After 15 min, the reaction was stopped with ?4 volume of 20% sulfosalicylic acid. After centrifuging, the reaction tube in a Beckman Microfuge for 5 min, NEM-MEA was quantitated in the supernatant by automated ion exchange chromatography using a Beckman 121 M amino analyzer. The conditions below were used on the amino acid analyzer to permit quantitation of NEM-MEA, and by utilizing two columns and automatic sample injection, it was possible to assay an average of one sample every 35 min. Jacketed 15 cm column assemblies were packed with Durrum DC-6A resin to form a 0.28 by 7.0 cm bed. Column temperature was 50°C. One hundred pliters of sample were injected onto the column. Flow rate was adjusted to approximately 10.5 ml/hr. All buffers contained 5 drops of pentachlorophenol solution, 5 mg/ml in ethanol (Pierce Chemical Co.), and 0.6 to 1.2 ml of Brij 35 detergent, 30% solution (Pierce Chemical Co.) per liter. The sequence and timing of sodium citrate buffers were as follows: 0.44 N (pH 4.00) for 3 min; 0.40 N (pH 5.03) for 7 min; and 1.0 N (pH 6.40) for 40 min. NEM-MEA eluted as an isolated peak with a retention time of approximately 47 min. NEM-MEA (0.1 to 0.2 nmoles) applied to the column was the minimum which could be reliably quantitated. NEM-MEA standards were made using known amounts of MEA, adding DTT, and reacting with excess NEM under nitrogen.
Appropriate blanks for the panthetheinase assay contained either no enzyme or enzyme which had been boiled for 60 sec; both gave equivalent results and yielded no measurable NEM-MEA. Appropriate internal and external standards of NEM-MEA Cystinotic, no cysteamine (10 mg/kg/day) the former simultaneously had grossly elevated leukocyte cystine levels whereas the latter did not.
DISCUSSION
There is no evidence for decreased enzymatically catalyzed cystine reduction or metabolism in cystinotic cells (21, (27) (28) (29) 41) and little support for the presence of significant amounts of cystine-reducing activity in either normal or cystinotic lysosomes (35, 40, 46, 47, 49) . Cystinotic cells have normal reduced glutathione content (27, 34) . Because cysteamine supplied exogenously can reduce cystinotic intracellular cystine levels to near normal (42) , the possibility that cystinosis might be due to a defect in endogenous MEA generation needed critical evaluation. Demonstration of a defect in MEA production in cystinosis might be accomplished by measurement of pantetheinase activity and/or of cell MEA levels.
The only known source of endogenous MEA is breakdown of pantetheine, involved in coenzyme A catabolism (Figure 1 ). This degradative pathway permits cysteamine generation and pantothenate recovery. Enzymatic degradation of CoA was described by Lipmann et al. and Novelli et al. (25) and subsequent important studies related to pantetheine catabolism have been performed by Dupre et al. (using horse kidney) (4, 6, 8, 11, (13) (14) (15) (16) (17) and Abiko et al. (rat liver and kidney) (1) (2) (3) 26, 36) . In rat liver, CoA is degraded to phosphopantetheine by a lysosomal acid phosphatase and a nuclear and microsomal plasma membrane pyrophosphatase. Further dephosphorylation to PTSH probably occurs before a specific and irreversible amidase (pantetheinase) catalyzes cleavage to PoA and MEA. Pantetheinase activity is located primarily in the microsomal-lysosomal fraction of rat liver and rat kidney (2) .
Measurement of MEA levels directly in rodent tissues has been reported by Huxtable et al. (20) . MEA reacted with phthalic anhydride-1-14C to yield N-(2-thi0ethyl)-phthalirnide-'~C, which was isolated by thin-layer chromatography and identified by mass spectrometry. Estimated levels of MEA in rats were 0.17 nmole/g tissue in kidney, 0.21 in liver, 0.25 in muscle, 0.68 in brain and 2.61 in heart. With this method, large tissue samples were required, and recoveries of exogenous MEA were less than 3%. These studies, however, provided evidence that MEA is an endogenous metabolite. We describe here a new method for measuring cysteamine either directly in biologic samples or as an end product of pantetheinase activity using reduction with DTT, reaction with NEM, and quantitation of MEA-NEM on an amino acid analyzer. The method is rapid, nonradioactive, and easy to use on small samples. Exogenous MEA is quantitatively recovered in this system.
Utilizing this assay system, cystinotic cell extracts were not different from normal with regard to total activity, apparent K,, or pH optimum of pantetheinase. These observations suggest a normal capacity for cysteamine generation in cystinotic cells and are the first of which are aware to demonstrate PTSH cleavage activity in human tissues.
Furthermore, we were able to directly measure MEA content in leukocytes from normal subjects and from cystinotic patients receiving either no cysteamine or doses of cysteamine inadequate to normalize their leukocyte cystine content. These results also provide no support for the hypothesis that cystinosis is caused by endogenous cysteamine deficiency.
The studies of human pantetheinase activity reported here are derived from analysis of unpurified preparations. Further characterization of pantetheinase purified from human tissues would be of considerable interest, but is unlikely to alter the fundamental conclusion of our studies with regard to cystinosis. The present investigations indicate that a defect in cysteamine generation is most unlikely to represent the fundamental molecular lesion in this disease.
